Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Revenues
Total revenues	$ 501,830,000	$ 367,741,000
Cost and expenses
Research and development	129,078,000	88,637,000
Selling, general and administrative	266,864,000	194,278,000
Total cost and expenses	581,007,000	442,055,000
Loss from operations	(79,177,000)	(74,314,000)
Interest expense	(1,005,000)	(3,124,000)
Interest and other income, net	13,419,000	10,267,000
Loss before income taxes	(66,763,000)	(67,171,000)
Income tax expense	(173,000)	(428,000)
Net loss	(66,936,000)	(67,599,000)
Unrealized gain on available-for-sale securities, net of tax	147,000	893,000
Comprehensive loss	$ (66,789,000)	$ (66,706,000)
Net loss per share (Note 12):
Basic (in dollars per share)	$ (0.50)	$ (0.56)
Diluted (in dollars per share)	$ (0.50)	$ (0.56)
Weighted-average number of shares used in computing basic and diluted net loss per share:
Basic (in shares)	134,750	120,814
Diluted (in shares)	134,750	120,814
Product
Revenues
Total revenues	$ 500,036,000	$ 364,672,000
Cost and expenses
Cost of revenues	184,613,000	158,833,000
Licensing and other
Revenues
Total revenues	1,794,000	3,069,000
Cost and expenses
Cost of revenues	$ 452,000	$ 307,000